Ingredient or product comparison
Quickcomparison
Dose Range Snap-8 3–10 % Acetyl Hexapeptide-3 (Argireline) 5%–10% % Frequency Once daily Administration Topical application Topical Cycle Length Ongoing/indefinite Onset Speed Moderate (1-2 weeks) Evidence Level Moderate human trials (Phase 1-2) Limited human
This source-based comparison does not add ratings or recommend a winner.
- Dose Range
- Snap-8
- 3–10 %
- Acetyl Hexapeptide-3 (Argireline)
- 5%–10% %
- Frequency
- Once daily
- Administration
- Topical application
- Topical
- Cycle Length
- Ongoing/indefinite
- Onset Speed
- Moderate (1-2 weeks)
- Evidence Level
- Moderate human trials (Phase 1-2)
- Limited human trials
- Efficacy